Stockreport

Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform

Perspective Therapeutics, Inc.  (CATX) 
PDF Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M NIH Grant to Develop Di [Read more]